InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2024-04-26 00:00:00 ET · period of report 2024-04-25 · accession 0001127602-24-013462 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-26 2024-04-25 GILD Telman Deborah H EVP, GC, Corp. Affairs F - Tax $65.27 -158 14.1K -1% -$10.3K
D 2024-04-26 2024-04-25 GILD Telman Deborah H EVP, GC, Corp. Affairs M - OptEx — +515 14.3K +4% —
D 2024-04-26 2024-04-25 GILD Telman Deborah H EVP, GC, Corp. Affairs M - OptEx — -515 39.6K -1% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-04-25 F D 158 $65.27 14,114 D — —
2 Common Common Stock 2024-04-25 M A 515 — 14,272 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3 Derivative Restricted Stock Unit 2024-04-25 M D 515 — 39,568 D — · — to — 515 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.